Genedata AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Genedata AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014072
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Basel, Switzerland.

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genedata AG, Medical Devices Deals, 2011 to YTD 2017 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genedata AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
Licensing Agreements 14
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata Expands Licensing Agreement with MorphoSys 20
Takeda Expands Licensing Agreement With Genedata For Proteomics And Metabolomics Experiments 21
Genedata AG – Key Competitors 22
Genedata AG – Key Employees 23
Genedata AG – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Feb 21, 2017: Genedata Expands Into United Kingdom 25
Product News 26
Jun 06, 2017: Genedata Announces New Solution for Efficient Analysis of High-Throughput Automated Patch Clamp Experiments 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Genedata AG, Pharmaceuticals & Healthcare, Key Facts 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genedata AG, Deals By Therapy Area, 2011 to YTD 2017 8
Genedata AG, Medical Devices Deals, 2011 to YTD 2017 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata Expands Licensing Agreement with MorphoSys 20
Takeda Expands Licensing Agreement With Genedata For Proteomics And Metabolomics Experiments 21
Genedata AG, Key Competitors 22
Genedata AG, Key Employees 23
Genedata AG, Subsidiaries 24

★海外企業調査レポート[Genedata AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Zayo Group Holdings Inc (ZAYO):企業の財務・戦略的SWOT分析
    Zayo Group Holdings Inc (ZAYO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tata Steel Group:企業の戦略・SWOT・財務情報
    Tata Steel Group - Strategy, SWOT and Corporate Finance Report Summary Tata Steel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Accugenomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Tesson Holdings limited:戦略・SWOT・企業財務分析
    Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report Summary Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • EDF Energy Holdings Ltd:発電所・企業SWOT分析
    EDF Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Impel NeuroPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • Hong Kong Polytechnic University:製薬・医療:M&Aディール及び事業提携情報
    Summary Hong Kong Polytechnic University (HKPU) is an educational university that provides research, training and professional education services. The university offers undergraduate, postgraduate, and doctoral level programs; joint research, academic program collaboration, research programs, confer …
  • Molnlycke Health Care AB:企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ANGLE plc (AGL):企業の製品パイプライン分析2018
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • CK Hutchison Holdings Ltd:企業のM&A・事業提携・投資動向
    CK Hutchison Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CK Hutchison Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Olea Medical SA-医療機器分野:企業M&A・提携分析
    Summary Olea Medical SA (Olea Medical), a subsidiary of Toshiba Medical Systems Corp is a healthcare technology company that designs and markets medical imaging software products to healthcare industry. The company’s products include advanced MR and CT perfusion imaging post-processing software prod …
  • Ambuja Cements Limited:企業の戦略・SWOT・財務情報
    Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report Summary Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Apollo Global Management Inc:企業の戦略・SWOT・財務分析
    Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report Summary Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Litgrid AB (LGD1L):企業の財務・戦略的SWOT分析
    Litgrid AB (LGD1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CMS Energy Corporation (CMS)-エネルギー分野:企業M&A・提携分析
    Summary CMS Energy Corporation (CMS Energy) is an energy utility which provides electricity, natural gas, and banking services. It generates, procures, transmits, distributes, and sells energy. The company produces power from coal, oil and gas, hydro, wind, and solar sources. CMS Energy purchases, t …
  • BJ’s Restaurants, Inc.:企業の戦略・SWOT・財務情報
    BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nissin Foods Holdings Co Ltd.:企業の戦略・SWOT・財務分析
    Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • American Cruise Lines, Inc.:企業の戦略・SWOT・財務情報
    American Cruise Lines, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Cruise Lines, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆